Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study
- PMID: 29205310
- PMCID: PMC5826592
- DOI: 10.1002/cncr.30881
Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study
Abstract
Background: Stomach cancer was a leading cause of cancer-related deaths early in the 20th century and has steadily declined over the last century in the United States. Although incidence and death rates are now low, stomach cancer remains an important cause of morbidity and mortality in black, Asian and Pacific Islander, and American Indian/Alaska Native populations.
Methods: Data from the CONCORD-2 study were used to analyze stomach cancer survival among males and females aged 15 to 99 years who were diagnosed in 37 states covering 80% of the US population. Survival analyses were corrected for background mortality using state-specific and race-specific (white and black) life tables and age-standardized using the International Cancer Survival Standard weights. Net survival is presented up to 5 years after diagnosis by race (all, black, and white) for 2001 through 2003 and 2004 through 2009 to account for changes in collecting Surveillance, Epidemiology, and End Results Summary Stage 2000 data from 2004.
Results: Almost one-third of stomach cancers were diagnosed at a distant stage among both whites and blacks. Age-standardized 5-year net survival increased between 2001 to 2003 and 2004 to 2009 (26.1% and 29%, respectively), and no differences were observed by race. The 1-year, 3-year, and 5-year survival estimates were 53.1%, 33.8%, and 29%, respectively. Survival improved in most states. Survival by stage was 64% (local), 28.2% (regional), and 5.3% (distant).
Conclusions: The current results indicate high fatality for stomach cancer, especially soon after diagnosis. Although improvements in stomach cancer survival were observed, survival remained relatively low for both blacks and whites. Primary prevention through the control of well-established risk factors would be expected to have the greatest impact on further reducing deaths from stomach cancer. Cancer 2017;123:4994-5013. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.
Keywords: CONCORD study; Epidemiology; National Program of Cancer Registries (NPCR); Surveillance; and End Results (SEER); cancer registries; gastric cancer; population-based cancer survival; stomach cancer.
Published 2017. This article is a U.S. Government work and is in the public domain in the USA.
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
Figures


Similar articles
-
Lung cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):5079-5099. doi: 10.1002/cncr.31029. Cancer. 2017. PMID: 29205305 Free PMC article.
-
Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):5014-5036. doi: 10.1002/cncr.31076. Cancer. 2017. PMID: 29205304 Free PMC article.
-
Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Cancer. 2017 Dec 15;123 Suppl 24(Suppl 24):5160-5177. doi: 10.1002/cncr.31026. Cancer. 2017. PMID: 29205313 Free PMC article.
-
20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes: A Systematic Review of 157,258 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).J Insur Med. 2019;48(1):5-23. doi: 10.17849/insm-48-1-1-19.1. Epub 2019 Oct 14. J Insur Med. 2019. PMID: 31609640
-
Cancer of the Nasal Cavity, Middle Ear and Accessory Sinuses - 15 Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and Topographic Primary Sites: A Systematic Review of 13,404 Cases for Diagnosis Years 2000-2017: (NCI SEER*Stat 8.3.8).J Insur Med. 2024 Jul 1;51(2):77-91. doi: 10.17849/insm-51-2-77-91.1. J Insur Med. 2024. PMID: 39266003
Cited by
-
Essential updates 2021/2022: Perioperative and surgical treatments for gastric and esophagogastric junction cancer.Ann Gastroenterol Surg. 2023 Jun 29;7(5):698-708. doi: 10.1002/ags3.12711. eCollection 2023 Sep. Ann Gastroenterol Surg. 2023. PMID: 37663969 Free PMC article. Review.
-
Prognostic role of tumour-infiltrating lymphocytes assessed by H&E-stained section in gastric cancer: a systematic review and meta-analysis.BMJ Open. 2021 Jan 31;11(1):e044163. doi: 10.1136/bmjopen-2020-044163. BMJ Open. 2021. PMID: 33518526 Free PMC article.
-
Lenvatinib suppress FGF19-FGFR4 signaling to enhance antitumor immune response in gastric cancer.Gastric Cancer. 2025 May;28(3):397-408. doi: 10.1007/s10120-025-01596-9. Epub 2025 Feb 13. Gastric Cancer. 2025. PMID: 39948303
-
Gastric Cancer Among American Indian and Alaska Native Populations in the United States, 2005-2016.Am J Gastroenterol. 2020 Dec;115(12):1989-1997. doi: 10.14309/ajg.0000000000000748. Am J Gastroenterol. 2020. PMID: 32740090 Free PMC article.
-
Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.Front Immunol. 2022 Mar 22;13:854785. doi: 10.3389/fimmu.2022.854785. eCollection 2022. Front Immunol. 2022. PMID: 35392086 Free PMC article.
References
-
- Wingo PA, Cardinez CJ, Landis SH, et al. Long-term trends in cancer mortality in the United States, 1930–1998. Cancer. 2003;97:3133–3275. - PubMed
-
- Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev. 1986;8:1–27. - PubMed
-
- US Cancer Statistics Working Group. United States Cancer Statistics: 1999–2013 Incidence and Mortality [web-based report] Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute; 2016. [Accessed August 1, 2017]. Available at: www.cdc.gov/uscs.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical